Skip to main content
logo
Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.200
+0.040 (1.27%)
Jul 31, 2026, 3:55 PM HKT

HKG:8247 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
184.29184.29263.07289.07373.07348.23
Revenue Growth
-18.11%-29.95%-9.00%-22.52%7.13%7.06%
Gross Profit
70.9270.92108.4127.37146.28143.59
Operating Income
-53.84-53.84-37.29-19.4119.7425.38
Net Income
-51.14-51.14-42.53-11.658.11-1.14
Earnings Per Share
-0.35-0.35-0.29-0.080.06-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
44.3844.3874.9672.0984.3150.74
Total Debt
162.91162.91153.85151.45151.69173.53
Net Cash (Debt)
-118.54-118.54-78.89-79.36-67.38-122.8
Net Cash Growth
------
Net Cash Per Share
-0.82-0.82-0.55-0.55-0.47-0.85

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.84-25.8423.75-6.5644.5348.89
Capital Expenditures
-6.54-6.54-12.39-16.35-16.34-3.74
Free Cash Flow
-32.39-32.3911.36-22.9128.1945.15
Free Cash Flow Growth
-----37.56%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
38.48%38.48%41.21%44.06%39.21%41.23%
Operating Margin
-29.22%-29.22%-14.17%-6.72%5.29%7.29%
Pretax Margin
-36.49%-36.49%-22.70%-6.09%4.96%1.84%
Profit Margin
-27.75%-27.75%-16.17%-4.03%2.17%-0.33%
FCF Margin
-17.57%-17.57%4.32%-7.92%7.56%12.97%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----20.06-
P/FCF Ratio
--9.10-5.774.44
PS Ratio
2.261.600.390.360.440.58